title: Lymphoproliferative disorders after FK 506.
authors.forename: S
authors.initials: S
authors.lastname: Kitahara
authors.forename: M
authors.initials: M
authors.lastname: Makuuchi
authors.forename: S
authors.initials: S
authors.lastname: Kawasaki
authors.forename: S
authors.initials: S
authors.lastname: Ishizone
authors.forename: H
authors.initials: H
authors.lastname: Matsunami
authors.forename: N
authors.initials: N
authors.lastname: Kamada
authors.forename: H
authors.initials: H
authors.lastname: Kawarazaki
authors.forename: T
authors.initials: T
authors.lastname: Iwanaka
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D002648:Child; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016031:Liver Transplantation; D008223:Lymphoma / Q000139:chemically induced*; D008297:Male; D009378:Neoplasms, Multiple Primary / Q000139:chemically induced*; D016559:Tacrolimus
chemical_list: D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D016559:Tacrolimus